What chemotherapy would you consider to treat platinum resistant high grade serous ovarian cancer in patients with a low grade MDS from prior platinum/PARPi?  

Assuming low risk of progression to AML and eligible for low-risk chemotherapies per hematologic/oncology.

Answer from: at Community Practice
at Artemis Health Institute
Carboplatin-induced thrombocytopenia is a known ph...
Sign in or Register to read more